Literature DB >> 21910959

Development of stable isotope dilution assays for ochratoxin A in blood samples.

Markus Korn1, Oliver Frank, Thomas Hofmann, Michael Rychlik.   

Abstract

Two new stable isotope dilution assays were developed for the quantification of ochratoxin A in human blood samples for exposure studies. The methods based on two different sample extraction and cleanup procedures including liquid-liquid extraction with following immunoaffinity chromatography (IA) as well as a dispersive solid-phase extraction (DSPE) method. For detection, LC-MS/MS was applied. For the first time, exact quantitation of the reference compound ochratoxin A was performed by quantitative NMR spectroscopy (qNMR). Additionally, a comparison of different blood-drawing procedures revealed no differences for heparin plasma and serum whereas citrate plasma gave significantly lower results for the mycotoxin. Limits of detection (LOD: 0.02 ng/g (IA) vs 0.03 ng/g (DSPE)), limits of quantification (LOQ: 0.07 ng/g (IA) vs 0.08 ng/g (DSPE)), relative recovery (≥94%), precision, and linearity indicated excellent performance of the developed methods.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21910959     DOI: 10.1016/j.ab.2011.08.032

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  2 in total

1.  Biomonitoring using dried blood spots: detection of ochratoxin A and its degradation product 2'R-ochratoxin A in blood from coffee drinkers.

Authors:  Benedikt Cramer; Bernd Osteresch; Katherine A Muñoz; Hartmut Hillmann; Walter Sibrowski; Hans-Ulrich Humpf
Journal:  Mol Nutr Food Res       Date:  2015-06-22       Impact factor: 5.914

2.  Biomonitoring of ochratoxin A, 2'R-ochratoxin A and citrinin in human blood serum from Switzerland.

Authors:  Alexandra Jaus; Peter Rhyn; Max Haldimann; Beat J Brüschweiler; Céline Fragnière Rime; Judith Jenny-Burri; Otmar Zoller
Journal:  Mycotoxin Res       Date:  2022-04-20       Impact factor: 4.082

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.